68GaNOTA-Anti-MMR-VHH2
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 68GaNOTA-Anti-MMR-VHH2, covering 2023-11-18 to 2024-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT [Phase 1, Phase 2]